Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Research question</h3><p>Whether melatonin can provide non-invasive ovarian protection against damage caused by cis-diamminedichloroplatinum (cisplatin) and preserve fertility for female cancer patients? And what is the possible mechanism if it is the case?</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Design</h3><p>Athymic BALB/c-nu nude tumor-bearing female mice were employed to exclude the antagonistic effect towards cisplatin-based anticancer therapy and promoting cancer effect of melatonin. Sexually mature and newborn C57BL/6 female mice were used to evaluate the potential effects of melatonin towards ovarian follicle pool, pregnant rate and litter number for cisplatin-treated mice and their ovaries were used to perform Immunohistochemistry, TUNEL and gene array to explore the underlying mechanism. We also isolated granulosa cells to confirm the potential protective mechanism of melatonin</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Not only could melatonin enhance the anti-cancer effect of cisplatin in tumor-bearing nude mice, but also it could reduce ovarian toxicity and preserved long-term fertility in cisplatin treated C57BL/6 female mice. Mechanistically, when co-administrated, melatonin could reduce DNA damage and relieve toxicity of lipid peroxidation in ovary caused by cisplatin. Specially, melatonin could largely removelipid peroxidation in granulosa cells and thus prevent ovarian follicles from being depleted.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Melatonin has potential to be used as a chemotherapeutic adjuvant to improve anti-cancer outcome and to preserve ovarian function for cisplatin chemotherapy simultaneously. Notably, its DNA protection and antioxidant effects on follicles may benefit female cancer survivors and prevent premature ovarian failure (POF) as well as fertility loss caused by chemotherapy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">KEY MESSAGE</h3><p>Ovarian reserve preservation and its mechanism of melatonin against cisplatin-induced ovarian damage have been explored. The better control of tumor and better ovarian reserve and fertility of female mice when melatonin was co-administrated with cisplatin indicates melatonin may be a promising fertoprotective agent for cisplatin-treated female cancer patients.</p>

Melatonin-Assisted Cisplatin Suppresses Urinary Bladder Cancer Cell Proliferation and Growth through Inhibiting PrPC-Regulated Cell Stress and Cell Proliferation Signaling

Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

CDDP Inhibition of Telomerase Activity in Uveal Melanoma Cells

Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin

[Effects of Cisplatin on Telomerase Activity of Human Choroidal Melanoma Cells].

Cisplatin Inhibits Bladder Cancer Proliferation Through cGAS-STING Pathway.

Cisplatin Inhibits the Progression of Bladder Cancer by Selectively Depleting G-MDSCs: A Novel Chemoimmunomodulating Strategy

Melatonin regulates cancer migration and stemness and enhances the anti-tumour effect of cisplatin

Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis via inhibiting PI3K/AKT/mTOR/MMPs signaling

Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice

Programmed Cell Death 4 Overexpression Enhances Sensitivity to Cisplatin Via the JNK/c-Jun Signaling Pathway in Bladder Cancer.

Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway

Melatonin alleviates cisplatin-induced mice spermatogenesis defects

Activation of MT1/MT2 to Protect Testes and Leydig Cells against Cisplatin-Induced Oxidative Stress through the SIRT1/Nrf2 Signaling Pathway

Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL‐17 signaling pathway gene LCN2 in castration‐resistant prostate cancer

Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK/Parkin/mitophagy axis

Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats

Melittin Inhibits Proliferation, Migration and Invasion of Bladder Cancer Cells by Regulating Key Genes Based on Bioinformatics and Experimental Assays

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Modulating Effect of Mitomycin or Cisplatin on Lymphokine-Activated Killer Cell Proliferation and Antitumor Activity to Bladder Cancer Cell Lines in Vitro

Melatonin Mitigates Cisplatin-Induced Submandibular Gland Damage by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Fibrosis